Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China flag China · Delayed Price · Currency is CNY
129.56
-1.32 (-1.01%)
Nov 18, 2026, 3:00 PM CST

SHA:600436 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,3172,1592,9772,7972,4722,432
Depreciation & Amortization
120.59120.5994.6102.3880.36133.49
Other Amortization
8.518.519.9126.3115.3415.96
Loss (Gain) From Sale of Assets
-3.41-3.41-4.66-1.5-11.48-28.91
Asset Writedown & Restructuring Costs
-0.39-0.390.790.541.82.34
Loss (Gain) From Sale of Investments
-343.76-343.76-136.79-134.51-75.19-23.35
Provision & Write-off of Bad Debts
28.9528.952.9412.27-6.787.1
Other Operating Activities
2,69219.4460.289.36123.88100.42
Change in Accounts Receivable
-50.42-50.42272.9-181.924,258-2,089
Change in Inventory
-1,721-1,721-1,600-758.78-199.39-261.56
Change in Accounts Payable
-222.55-222.55-363.45306.43205.02232.58
Operating Cash Flow
1,90777.031,3142,2076,873462.27
Operating Cash Flow Growth
280.31%-94.14%-40.47%-67.89%1386.79%-68.49%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-586.64-339.8-1,068-141.87-175.37-92.17
Sale of Property, Plant & Equipment
0.073.444.131.2513.745.31
Investment in Securities
2,1872,0472,354-2,658-6,170143.32
Other Investing Activities
-1,60227.1234.5224.1227.0321.82
Investing Cash Flow
-1.931,7381,324-2,774-6,30578.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5.014.9--1,410
Long-Term Debt Issued
-910.341,1611,1981,593-
Total Debt Issued
882.92915.351,1661,1981,5931,410
Short-Term Debt Repaid
------1,356
Long-Term Debt Repaid
--1,018-1,272-1,180-1,429-31.79
Lease Payments
-46.51-46.51-41.97-38.61-33.17-31.79
Total Debt Repaid
-953.46-1,018-1,272-1,180-1,429-1,387
Net Debt Issued (Repaid)
-70.54-102.31-106.317.85164.1223.09
Common Dividends Paid
-968.53-1,968-2,127-784.64-760.63-569.21
Other Financing Activities
4.96-4.67-6.98-2.5120.695.9
Financing Cash Flow
-1,034-2,075-2,241-769.3-575.82-540.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-10.69-2.268.162.4311.44-4.62
Net Cash Flow
860.7-261.67405.7-1,3343.84-4.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,321-262.77245.412,0656,698370.11
Free Cash Flow Growth
---88.11%-69.17%1709.66%-64.69%
Free Cash Flow Margin
16.70%-2.92%2.27%20.53%77.04%4.61%
Free Cash Flow Per Share
2.19-0.440.413.4211.110.61
Levered Free Cash Flow
-840.68-848.65-665.121,4111,3701,610
Unlevered Free Cash Flow
-822.33-828.81-641.611,4341,3941,631
Free Cash Flow After Leases
1,274-309.28203.452,0266,664338.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
664.63771.851,1671,155989.67969.09
Change in Working Capital
-1,912-1,912-1,690-685.584,273-2,177